Correlation Between Innate Pharma and Etablissements Maurel

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Innate Pharma and Etablissements Maurel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innate Pharma and Etablissements Maurel into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innate Pharma and Etablissements Maurel et, you can compare the effects of market volatilities on Innate Pharma and Etablissements Maurel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innate Pharma with a short position of Etablissements Maurel. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innate Pharma and Etablissements Maurel.

Diversification Opportunities for Innate Pharma and Etablissements Maurel

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between Innate and Etablissements is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Innate Pharma and Etablissements Maurel et in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Etablissements Maurel and Innate Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innate Pharma are associated (or correlated) with Etablissements Maurel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Etablissements Maurel has no effect on the direction of Innate Pharma i.e., Innate Pharma and Etablissements Maurel go up and down completely randomly.

Pair Corralation between Innate Pharma and Etablissements Maurel

Assuming the 90 days trading horizon Innate Pharma is expected to under-perform the Etablissements Maurel. In addition to that, Innate Pharma is 1.18 times more volatile than Etablissements Maurel et. It trades about -0.18 of its total potential returns per unit of risk. Etablissements Maurel et is currently generating about -0.09 per unit of volatility. If you would invest  635.00  in Etablissements Maurel et on August 29, 2024 and sell it today you would lose (142.00) from holding Etablissements Maurel et or give up 22.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Innate Pharma  vs.  Etablissements Maurel et

 Performance 
       Timeline  
Innate Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Innate Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Etablissements Maurel 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Etablissements Maurel et has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Etablissements Maurel is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Innate Pharma and Etablissements Maurel Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Innate Pharma and Etablissements Maurel

The main advantage of trading using opposite Innate Pharma and Etablissements Maurel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innate Pharma position performs unexpectedly, Etablissements Maurel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Etablissements Maurel will offset losses from the drop in Etablissements Maurel's long position.
The idea behind Innate Pharma and Etablissements Maurel et pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Bonds Directory
Find actively traded corporate debentures issued by US companies
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Share Portfolio
Track or share privately all of your investments from the convenience of any device